Statin Induction of Liver Fatty Acid-Binding Protein (L-FABP) Gene Expression Is Peroxisome Proliferator-activated Receptor-α-dependent

Archive ouverte

Landrier, Jean-François | Thomas, Charles | Grober, Jacques | Duez, Hélène | Percevault, Frédéric | Souidi, Maamar | Linard, Christine | Staels, Bart | Besnard, Philippe

Edité par CCSD ; American Society for Biochemistry and Molecular Biology -

International audience. Statins are drugs widely used in humans to treat hypercholesterolemia. Statins act by inhibiting cholesterol synthesis resulting in the activation of the transcription factor sterol-responsive element-binding protein-2 that controls the expression of genes involved in cholesterol homeostasis. Statin therapy also decreases plasma triglyceride and non-esterified fatty acid levels, but the mechanism behind this effect remains more elusive. Liver fatty acid-binding protein (L-FABP) plays a role in the influx of long-chain fatty acids into hepatocytes. Here we show that L-FABP is a target for statins. In rat hepatocytes, simvastatin treatment induced L-FABP mRNA levels in a dose-dependent manner. Moreover, L-FABP promoter activity was induced by statin treatment. Progressive 5'-deletion analysis revealed that the peroxisome proliferator-activated receptor (PPAR)-responsive element located at position -67/-55 was responsible for the statin-mediated transactivation of the rat L-FABP promoter. Moreover, treatment with simvastatin and the PPARalpha agonist Wy14,649 resulted in a synergistic induction of L-FABP expression (mRNA and protein) in rat Fao hepatoma cells. This effect was also observed in vivo in wild-type mice but not in PPARalpha-null animals demonstrating the direct implication of PPARalpha in L-FABP regulation by statin treatment. Statin treatment resulted in a rise in PPARalpha mRNA levels both in vitro and in vivo and activated the mouse PPARalpha promoter in a reporter assay. Altogether, these data demonstrate that L-FABP expression is up-regulated by statins through a mechanism involving PPARalpha. Moreover, PPARalpha might be a statin target gene. These effects might contribute to the triglyceride/non-esterified fatty acid-lowering properties of statins.

Consulter en ligne

Suggestions

Du même auteur

Modification of intestinal bile acid-binding protein (I-BABP) expression after exposure to ionising radiation

Archive ouverte | Scanff, Pascale | CCSD

International audience

FXRE can function as a LXRE in the promoter of human ileal bile acid-protein (I-BABP) gene

Archive ouverte | Landrier, Jean-François | CCSD

International audience. Ileal bile acid‐binding protein (I‐BABP) is a 14 kDa cytosolic protein which binds bile acids with a high affinity. It is thought to be implicated in the enterohepatic circulation of bile aci...

Regulation of adipose tissue and adipocyte physiology by vitamin D. La vitamine D régule la physiologie du tissu adipeux et de l’adipocyte

Archive ouverte | Landrier, Jean-François | CCSD

International audience. Numerous studies have demonstrated the active role of vitamin D and its metabolites in key physiological processes in the biology of adipose tissue and adipocytes, such as adipogenesis, energ...

Chargement des enrichissements...